KRAVICZ MARCELO HENRIQUE

Sierri, G., Dal Magro, R., Vergani, B., Leone, B., Formicola, B., Taiarol, L., et al. (2022). Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(1) [10.3390/ijms23010102]. Dettaglio

Taiarol, L., Bigogno, C., Sesana, S., Kravicz, M., Viale, F., Pozzi, E., et al. (2022). Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics. CANCERS, 14(12) [10.3390/cancers14122978]. Dettaglio

Taiarol, L., Formicola, B., Fagioli, S., Sierri, G., D'Aloia, A., Kravicz, M., et al. (2021). The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment. CANCERS, 13(16) [10.3390/cancers13164001]. Dettaglio

Borgheti-Cardoso, L., Viegas, J., Silvestrini, A., Caron, A., Praça, F., Kravicz, M., et al. (2020). Nanotechnology approaches in the current therapy of skin cancer. ADVANCED DRUG DELIVERY REVIEWS, 153, 109-136 [10.1016/j.addr.2020.02.005]. Dettaglio

Viegas, J., Praça, F., Caron, A., Suzuki, I., Silvestrini, A., Medina, W., et al. (2020). Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 10(3), 646-660 [10.1007/s13346-020-00723-6]. Dettaglio